Aulea Medical, Inc.

Aulea Medical manufactures the Veloxion all-in-one system, a single-use, integrated platform for benign prostatic hyperplasia (BPH) treatment via transurethral resection of the prostate (TURP). The system combines fluid management, video imaging, and radiofrequency energy generation in a single console to streamline urology workflows. Key clinical innovations include automated intravesical pressure monitoring and control, motorized plasma cutting technology, multi-directional resection capability, and immediate tissue evacuation to maintain visualization. The Veloxion is designed to reduce BPH treatment time to approximately 20 minutes compared to standard TURP (60 minutes), enable same-day procedures in ambulatory surgery centers for prostate glands ranging 30–200g, and eliminate infection risk and cross-contamination through single-use endoscopic devices. The system requires minimal setup and teardown, reducing procedure time and cost of ownership. Aulea targets urology departments, ambulatory surgery centers, and specialty urology practices. The company emphasizes safety (pressure management to prevent bladder perforation, sterile single-use design), simplicity (plug-and-play console, automated fluid evacuation), and procedural efficiency. Manufacturing capabilities include single-use device fabrication and integrated RF energy generation systems.